Alan F. Holmer

Alan F. Holmer has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Corbus Pharmaceuticals Holdings, Inc. and Inspire Pharmaceuticals Inc. In total, 9 filings cover trades dated from 13 May 2011 to 30 May 2025.

No open-market sale appears; the market trades are 3 purchases worth €12k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants and 3 option exercises.

In size, the median ticket on the buying side is €2,867.

The record was last updated on 2 June 2025 with a share grant in Corbus Pharmaceuticals Holdings, Inc. The most recent open-market purchase was published on 12 May 2017, 3,452 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.